RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

Add to Collection
Clinical Guidelines and Recommendations AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2022 - Elsevier

Chapter : Section13, Section15, Section16, Section17, Section23, Section24, Section25, Section2, Section5, Section6
Journal Year : 2022
Cited by : 43

… However, cost-wise molnupiravir is comparatively cheaper compared to all other agents. … with a relatively lower cost. These findings are very important in the context of India, where only …..... Read More

Keywords : ['update practical guideline', 'emergency use authorization', 'use', 'treatment', 'molnupiravir', 'comparison', 'agent']
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1871402122000108
Google Scholar Link : https://scholar.google.com/scholar?cites=9100677084331297709&as_sdt=5,47&sciodt=0,47&hl=en&num=20